Description: Kanabo Group Plc focuses on the research and development, production, and sale of medical cannabis products to treat CNS disorders. The company intends to offer cannabis-derived products for medical patients; and non-THC products for CBD consumers. It also provides VapePod, a medically certified delivery system for cannabis extracts. The company was founded in 2017 and is based in London, the United Kingdom.
Home Page: www.kanabogroup.com
KNB Technical Analysis
Churchill House
London,
NW4 4DJ
United Kingdom
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Avihu Tamir | CEO & Exec. Director |
| Mr. David Sack | Co-founder |
| Mr. Assaf Vardimon | Chief Financial Officer |
| Howard Rubenstein | Company Sec. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5483 |
| Price-to-Sales TTM: | 30.1401 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |